2025 Annual NEALS Meeting
/The 2025 Annual Northeast Amyotrophic Lateral Sclerosis Consortium® (NEALS) Meeting was held in Clearwater, FLA this October 7-10, 2025. This year marked the 30th year of NEALS, “three decades of collaboration, innovation, and commitment to advancing ALS research,” and the ALS Hope Foundation was noted to be one of the early supporters of the consortium.
Before the official start to the meeting, there a day filled with committee meetings, educational events, and Outcome Training for the clinical trials. Kathleen Hatala, Sara Feldman and John Furey attended these meetings and Dr. Terry Heiman-Patterson was a faculty member of the Clinical Learning Research Institute (CRLI). The evening ended with a screening of Dr. Rick Bedlack’s documentary, Stitching Strength.
Day 1 started with Dr. James Berry and Dr. Jinsy Andrews reviewing the past 30 years of NEALS. NEALS was founded as an independent, non-profit group of clinical sites in the Northeast US that collaboratively conducted research and now consists of international clinical research centers. The presentations focused on research updates from NEALS affiliated trials and lighting science talks co-chaired by the Scientific Advisory Board.
The day concluded with the first poster session.
We are pleased to note that we had several members of the clinic and lab in attendance at the meetings and presenting posters.
Dr. Terry Heiman-Patterson chairs the abstract committee and Dr. Lyle Ostrow is a member and a judge on the committee.
All of the poster presentations will be included at the end.
Day 2 began with an excellent session on Partners in Discovery: Research Ambassadors Driving Change which was chaired by Dr. Rick Bedlack and included Dr. Terry Heiman-Patterson as a panelist along with ALS Advocates, Andrea Lytle Peet, John Peffer, and Jean Swidler. They each told their story and answered questions from the audience on what being a Research Ambassador means to them.
Dr. Terry Heiman-Patterson then lead the next session on the ALS Better Care Act Update. The afternoon sessions focused on future directions in treating both sporadic and genetic ALS. The day concluded with the second poster session.
Day 3 began with a discussion on Uniting for Impact: Updates from the NEALS ALS Organizations Forum. Our Executive Director, Jamey Piggott, attends these quarterly meetings. This was followed by the Awards presentations and the ALS Residence Initiative (ALSRI) was the recipient of the Gupta Family Endowed Prize for Innovation in ALS Care. Steve Saling, CEO of ALSRI, and Barry Berman, CEO of Chelsea Jewish Lifecare accepted the prize.
The final session of Platform Presentations was chaired by Dr. Terry Heiman-Patterson.
It was an excellent conference overall with three amazing days of presentations, panels and posters. Three decades after it began, NEALS remains a place where the research keeps moving forward and the collaborations run deep.
POSTERS:
We are pleased to be able to share with you the work that was presented at the NEALS Symposium that came from the work being done in the Dr. Robert Sinnott Lab. These studies build directly on the invaluable contributions of participants in our Natural History Study and ALS Tissue Bank.
Several posters we as the result of collaborations with others.
"ROAR-DIGAP: A Widely Inclusive, Largely Virtual Pilot Trial Utilizing DIGAP (Deep Integrated Genomics Analysis Platform) To Personalize Treatments" is work we are doing with Dr. Rick Bedlack at Duke. Others included the work done with Northeast Amyotrophic Lateral Sclerosis (NEALS) Biorepository and Evaluating the Precision of Quantitative Voice Characteristics as Endpoints in ALS Clinical Trials with the Healey Platform Trial data.
We continue our collaboration with Dr. Hasan Ayaz at Drexel University for our research on Brain Computer Interfaces.
And designing a cervical support that delivers improved comfort remains a project, but is one step closer to a product!
Veteran ALS Action Committee team member Mandi Bailey presented a poster at NEALS, "Navigating Complex Conversations in ALS."
Cassandra Haddad presented End the Legacy’s poster, "Informants (Study Partners) in Presymptomatic ALS Research: Highlighting uncharacterized and uncommunicated potential risks."
“I thought the NEALS experience was amazing. I think it reinforced why we do what we do, and I was pleasantly surprised by the overwhelmingly positive feedback we got for the neck brace. At NEALS I presented 3 different posters on the topics of a 3-d printed entirely customizable neck brace of pALS with dropped head syndrome, the prevalence and survival outcomes of pALS with and without cognitive and behavioral impairment, and the accuracy and effectiveness of using different conditions for brain-computer interface usage.
Meeting with everyone, especially patients and other researchers was the best part of NEALS for me as I think collaboration and getting our research out there is the key to helping pALS as quickly as possible, while maintaining a higher standard of care. I am deeply humbled and thankful for being able to advocate for, and work with such an amazing group of people, and I am excited for the progress we will all make between now and next NEALS.” Josh Miller
“As a first-time attendee, I was deeply moved by the stories shared by people living with ALS and inspired by the passion and dedication of everyone working to improve their lives. It was exciting to learn about emerging advances in research and diagnosis, including innovative eye-based technologies that may help detect disease earlier. I also appreciated the opportunity to connect with leaders from across academia and industry and to hear about new collaborative efforts shaping the future of ALS care. Our team is developing noninvasive brain–computer interface technologies to support natural communication and greater autonomy, and it was inspiring to see how this work aligns with the NEALS mission. I am grateful to Dr. Heiman-Patterson for welcoming us into this community and to everyone who shared valuable insights throughout the meeting.” Bartu Atabek
